Dr. Galvin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7700 Camino Real
Ste 200
Boca Raton, FL 33433Phone+1 561-869-6808
Education & Training
- Saint Louis UniversityMPH, Epidemiology, e.g. Cum Laude, 2003 - 2005
- University of Pennsylvania Health SystemFellowship, Neurological Rehabilitation, 1996 - 1997
- Medical College of Pennsylvania/Hahnemann University1995 - 1996
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 1993 - 1995
- Hackensack Medical Center1992 - 1993
- Rutgers New Jersey Medical SchoolClass of 1992
- Rutgers UniversityMS, Nutrition, 1986 - 1988
- New York UniversityBA, Chemistry, 1982 - 1986
Certifications & Licensure
- FL State Medical License 2015 - 2025
- NY State Medical License 2010 - 2015
- PA State Medical License 1994 - 2000
- NJ State Medical License 1993 - 1997
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Junior Faculty Career Development Award National Palliative Care Research Center, 2012
- KL2 Clinical and Translational Research Award NYU-HHC Clinical and Translational Science Institute, 2012
- Outstanding Contributor Alzheimer Research Forum, 2008
- Join now to see all
Clinical Trials
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
- Fox BioNet Project: LRRK2-002 Start of enrollment: 2018 May 16
Publications & Presentations
PubMed
- Refractory Psychosis as a Red Flag for End of Life in Individuals With Dementia With Lewy Bodies: A Case Series and Re-analysis of Prior Qualitative Data.Melissa J Armstrong, James E Galvin, Carol Manning, Bradley F Boeve, Gregory M Pontone
Alzheimer Disease and Associated Disorders. 2025-01-29 - Cognivuecharacterizes amyloid status and preclinical Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study.James E Galvin, Michael J Kleiman, Paul W Estes, Heather M Harris, Ernest Fung
Journal of Alzheimer's Disease. 2025-01-26 - Gait, balance, and physical performance as markers of early Alzheimer's disease and related dementia risk.Magdalena I Tolea, Amie Rosenfeld, Sam Van Roy, Lilah M Besser, Deirdre M O'Shea
Journal of Alzheimer's Disease. 2025-01-26
Journal Articles
- DOPAL, the MAO Metabolite of Dopamine is Responsible for Dopamine Neuron Loss and Triggers ?-Synuclein Aggregation in vitro.Burke WJ, Kumar VB, Pandey N, Franko MW, O’Dell M, Chung HD, and Galvin JE, Acta Neuropathologica
- Relationship of Cytotoxic Activity of Natural Killer Cells to Growth and Serum Zinc Levels of Female RIII Mice Fed Zinc.Bunk MJ, Galvin JE, Yung YP, Dnistrian AM, and Blaner WS, Nutr Can
- Increased Vulnerability of NFH-LacZ Transgenic Mouse to Traumatic Brain Injury-Induced Behavioral Deficits and Cortical Damage.84. Nakamura M, Saatman KE, Galvin JE, Scherbel U, Raghupathi R, Trojanowski JQ, McIntosh TK, J Cereb Blood Flow Metab
- Join now to see all
Books/Book Chapters
Press Mentions
- How to Drastically Reduce the Risk of Dementia After 55 Years of AgeFebruary 1st, 2025
- Cognition’s Positive Phase 2 ‘SHIMMER’ Study of Zervimesine (CT1812) in Dementia with Lewy Bodies (DLB) Will Be Presented in a Podium Presentation at ILBDCJanuary 30th, 2025
- New Study Finds Higher Lifetime Risk of Eventually Developing DementiaJanuary 18th, 2025
- Join now to see all
Grant Support
- Education And Information Transfer CoreNational Institute On Aging2010–2012
- Multicultural Community Dementia Screening.National Institute On Aging2011
- Dementia Of Parkinson Type: Clinicopathologic PhenotypeNational Institute On Aging2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: